Category Archives: Health

Dr. Imran Haque’s Horizon Internal Medicine Fills the Medical Services Void in Asheboro and Ramseur NC

As an internist, Dr. Imran Haque specializes in the diagnosis, prevention, and treatment of adult illnesses. Dr. Haque received his medical degree with honors from Santo Domingo’s Universidad Iberoamericana (UNIBE)in 1998. He furthered his education through the University of Virginia Internal Medicine Roanoke-Salem Program. Dr. Haque completed his Residency in Internal Medicine with the Virginia based Carilion Health System.

Dr. Imran Haque has been in practice for 19 years. He is currently licensed and practicing in North Carolina. His hospital affiliations are with Kindred Hospital-Greensboro and Asheboro’s Randolph Hospital. Dr. Haque has made it his mission to bring the good bedside manner back to medicine.

With offices in Asheboro and Ramseur, NC Dr. Imran Haque’s current practice is Horizon Internal Medicine. His business model for this practice is to provide medical services that are not available in the Asheboro Ramseur area.

Depending on their condition Dr. Haque’s patients use him as either a specialist or primary care physician. Horizon Internal Medicine’s website lists eight services provided by Dr. Imran Haque and his staff.

360 Resurfacing-
• 360 Resurfacing-Offered in both Asheboro and Ramseur this is the repairing of skin damage using a laser.
Laser Hair Removal-
• Laser Hair Removal-Available in both offices this procedure removes excess body hair.
Venus Body Contouring-
• Venus Body Contouring-Available in Asheboro VBC is the tightening of loose skin and or the diminishment of cellulite.
Physical Exams-
• Physical Exams-Asheboro only.
• Diabetes-Dr. Haque provides screening, treatment, and education in his Asheboro office.
Weight Managment
• Weight Managment-Offered in Asheboro this is primarily an educational program.
• Botox-Injections are given in the Asheboro practice to smooth facial lines and wrinkles.
Dermal Fillers-
• Dermal Fillers-Injections that augment the bodies supply of hyaluronic acid which gives volume to the face and lips.

The opinion that his patients have of Dr. Imran Haque speaks best of his skills as a physician. His patients gave him a four out of four-star rating on Web MD.

To Read More :




If you’re not in the biotechnology industry, you may not be familiar with Amicus Therapeutics; they’re recognized as global leaders when it comes to developing therapies for orphan diseases. Amicus Therapeutics has a proprietary platform of medicines and technologies to treat those who are living with rare, and in many cases, life altering diseases. Some of these diseases include Lysosomal Storage Disorders, which encompasses Fabry disease and Pompe disease; in addition, Amicus Therapeutics provides treatment for genetic connective skin disorders like Epidermolysis Bullosa. Amicus Therapeutics relies on inventive science and clinical programs to treat their patients; in 2016, Amicus announced that Migalastat, a drug intended to treat Fabry disease, was approved by the European Union after undergoing two phase III clinical trials, and would be incorporated into their drug therapies.




Amicus Therapeutics is based in Cranberry, NJ, and is committed to making a meaningful difference in the lives of their patients, as well as caregivers ( Founded in 2002, the company places a strong emphasis on developing enzyme replacement therapies and has worked in collaboration with top-tier pharmaceutical companies, like GlaxoSmithKline and JCR Pharmaceuticals in formulating an effective drug therapy to treat deficiency in the enzyme known as alpha-galactosidase. In fact, in 2008 Amicus opened a second facility in San Diego, as a means to further their research and broaden their operation.




The work done by Amicus Therapeutics has caught the attention of not only their contemporaries but also Hollywood celebrities; in 2010, they received a grant totaling $500,000 from the Michael J. Fox Foundation (AliveNewsPaper). The funds were intended to support collaborative studies with the David Geffen School of Medicine. In addition, they received a grant for over $200,000 from the Alzheimer’s Drug Discovery Foundation, which was intended to support clinical work.


Why do orphan diseases receive grants? To better understand the reasoning behind this, we need to address what an orphan disease is; an orphan disease is a disease that affects less than 200,000 people. Since only a small percentage of people are affected by these diseases, there is no financial incentive for private companies to develop and market drugs to treat them, and therefore companies like Amicus Therapeutics has to rely upon grants.